Rituximab treatment in resistant lupus nephritis: A single-center prospective study
CONCLUSION: Rituximab is a safe and effective therapeutic strategy for patients with resistant LN.PMID:38660888 | DOI:10.5414/CN111104 (Source: Clinical Nephrology)
Source: Clinical Nephrology - April 25, 2024 Category: Urology & Nephrology Authors: Shahzad Alam Mastakim Ahmed Mazumder Manjuri Sharma Pranab Jyoti Mahanta Manzoor Parry Prodip Kumar Doley Source Type: research
Incorporating genetic testing into a routine kidney clinic
In conclusion, utilizing genetic testing in a routine outpatient renal clinic did not cause any burden to either patients or nephrologists, with minimal administrative effort and no financial cost to our patients. We expect that genetic testing in the right setting should become routine in nephrology to achieve a patient-centered precision medicine with less invasive means of kidney disease diagnosis.PMID:38660889 | DOI:10.5414/CN111138 (Source: Clinical Nephrology)
Source: Clinical Nephrology - April 25, 2024 Category: Urology & Nephrology Authors: Jingjing Zhang Wing Zeng Seyed Hamrahian Omar H Maarouf Source Type: research
Application of improved glomerular filtration rate estimation by a neural network model in patients with neurogenic lower urinary tract dysfunction
CONCLUSION: The MLP-based model offered significant advantages in estimating GFR in Chinese NLUTD patients, and its application could be suggested in clinical practice.PMID:38629744 | DOI:10.5414/CN111150 (Source: Clinical Nephrology)
Source: Clinical Nephrology - April 17, 2024 Category: Urology & Nephrology Authors: Ying-Chun Ma Yang Xie Limin Liao Source Type: research
Physical functional capacity assessment in children with chronic kidney disease: A cross sectional observational study
CONCLUSION: Muscle strength and functional capacity were most impaired in Indian children on hemodialysis and best preserved in KTR.PMID:38629745 | DOI:10.5414/CN111295 (Source: Clinical Nephrology)
Source: Clinical Nephrology - April 17, 2024 Category: Urology & Nephrology Authors: Himani Goswami Harda Shah Kinnari Vala Shahenaz Kapadia Bharat Tiwari Anshuman Saha Source Type: research
Application of improved glomerular filtration rate estimation by a neural network model in patients with neurogenic lower urinary tract dysfunction
CONCLUSION: The MLP-based model offered significant advantages in estimating GFR in Chinese NLUTD patients, and its application could be suggested in clinical practice.PMID:38629744 | DOI:10.5414/CN111150 (Source: Clinical Nephrology)
Source: Clinical Nephrology - April 17, 2024 Category: Urology & Nephrology Authors: Ying-Chun Ma Yang Xie Limin Liao Source Type: research
Physical functional capacity assessment in children with chronic kidney disease: A cross sectional observational study
CONCLUSION: Muscle strength and functional capacity were most impaired in Indian children on hemodialysis and best preserved in KTR.PMID:38629745 | DOI:10.5414/CN111295 (Source: Clinical Nephrology)
Source: Clinical Nephrology - April 17, 2024 Category: Urology & Nephrology Authors: Himani Goswami Harda Shah Kinnari Vala Shahenaz Kapadia Bharat Tiwari Anshuman Saha Source Type: research
Application of improved glomerular filtration rate estimation by a neural network model in patients with neurogenic lower urinary tract dysfunction
CONCLUSION: The MLP-based model offered significant advantages in estimating GFR in Chinese NLUTD patients, and its application could be suggested in clinical practice.PMID:38629744 | DOI:10.5414/CN111150 (Source: Clinical Nephrology)
Source: Clinical Nephrology - April 17, 2024 Category: Urology & Nephrology Authors: Ying-Chun Ma Yang Xie Limin Liao Source Type: research
Physical functional capacity assessment in children with chronic kidney disease: A cross sectional observational study
CONCLUSION: Muscle strength and functional capacity were most impaired in Indian children on hemodialysis and best preserved in KTR.PMID:38629745 | DOI:10.5414/CN111295 (Source: Clinical Nephrology)
Source: Clinical Nephrology - April 17, 2024 Category: Urology & Nephrology Authors: Himani Goswami Harda Shah Kinnari Vala Shahenaz Kapadia Bharat Tiwari Anshuman Saha Source Type: research
Evaluating prescription of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in patients with diabetes and albuminuria
CONCLUSION: ACEi/ARB therapy was suboptimal in patients with diabetes, hypertension, and albuminuria. Non-adherence was associated with CKD stage, possibly because of concerns about adverse events and healthcare-related factors.PMID:38606848 | DOI:10.5414/CN111247 (Source: Clinical Nephrology)
Source: Clinical Nephrology - April 12, 2024 Category: Urology & Nephrology Authors: Kittiphan Chienwichai Phirada Chaloemwa Sorawat Sangkaew Arunchai Chang Source Type: research
Effect of cyclophosphamide combined with glucocorticoid therapy on idiopathic membranous nephropathy: A multicenter open-label randomized controlled trial
CONCLUSION: Cyclophosphamide combined with glucocorticoid therapy is effective for improving the overall remission rate and can suppress inflammatory responses and oxidative stress in patients with idiopathic membranous nephropathy.PMID:38606849 | DOI:10.5414/CN111287 (Source: Clinical Nephrology)
Source: Clinical Nephrology - April 12, 2024 Category: Urology & Nephrology Authors: Jianlin Wang Dong Bian Jian Sun Source Type: research
Evaluating prescription of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in patients with diabetes and albuminuria
CONCLUSION: ACEi/ARB therapy was suboptimal in patients with diabetes, hypertension, and albuminuria. Non-adherence was associated with CKD stage, possibly because of concerns about adverse events and healthcare-related factors.PMID:38606848 | DOI:10.5414/CN111247 (Source: Clinical Nephrology)
Source: Clinical Nephrology - April 12, 2024 Category: Urology & Nephrology Authors: Kittiphan Chienwichai Phirada Chaloemwa Sorawat Sangkaew Arunchai Chang Source Type: research
Effect of cyclophosphamide combined with glucocorticoid therapy on idiopathic membranous nephropathy: A multicenter open-label randomized controlled trial
CONCLUSION: Cyclophosphamide combined with glucocorticoid therapy is effective for improving the overall remission rate and can suppress inflammatory responses and oxidative stress in patients with idiopathic membranous nephropathy.PMID:38606849 | DOI:10.5414/CN111287 (Source: Clinical Nephrology)
Source: Clinical Nephrology - April 12, 2024 Category: Urology & Nephrology Authors: Jianlin Wang Dong Bian Jian Sun Source Type: research
Evaluating prescription of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in patients with diabetes and albuminuria
CONCLUSION: ACEi/ARB therapy was suboptimal in patients with diabetes, hypertension, and albuminuria. Non-adherence was associated with CKD stage, possibly because of concerns about adverse events and healthcare-related factors.PMID:38606848 | DOI:10.5414/CN111247 (Source: Clinical Nephrology)
Source: Clinical Nephrology - April 12, 2024 Category: Urology & Nephrology Authors: Kittiphan Chienwichai Phirada Chaloemwa Sorawat Sangkaew Arunchai Chang Source Type: research
Effect of cyclophosphamide combined with glucocorticoid therapy on idiopathic membranous nephropathy: A multicenter open-label randomized controlled trial
CONCLUSION: Cyclophosphamide combined with glucocorticoid therapy is effective for improving the overall remission rate and can suppress inflammatory responses and oxidative stress in patients with idiopathic membranous nephropathy.PMID:38606849 | DOI:10.5414/CN111287 (Source: Clinical Nephrology)
Source: Clinical Nephrology - April 12, 2024 Category: Urology & Nephrology Authors: Jianlin Wang Dong Bian Jian Sun Source Type: research
Evaluating prescription of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in patients with diabetes and albuminuria
CONCLUSION: ACEi/ARB therapy was suboptimal in patients with diabetes, hypertension, and albuminuria. Non-adherence was associated with CKD stage, possibly because of concerns about adverse events and healthcare-related factors.PMID:38606848 | DOI:10.5414/CN111247 (Source: Clinical Nephrology)
Source: Clinical Nephrology - April 12, 2024 Category: Urology & Nephrology Authors: Kittiphan Chienwichai Phirada Chaloemwa Sorawat Sangkaew Arunchai Chang Source Type: research
